Literature DB >> 12022240

Prevalence of hyperhomocysteinemia in an elderly population.

Jorge J Janson1, Carlos R Galarza, Alicia Murúa, Irene Quintana, Pablo A Przygoda, Gabriel Waisman, Luis Camera, Lucia Kordich, Margarita Morales, Luis M Mayorga, Mario I Camera.   

Abstract

BACKGROUND: Currently, total hyperhomocysteinemia (tHHcy) is a well-known condition linked to a higher risk of vascular disease. Prevalence of HHcy increases in elderly persons as the risk associated with it persists. Because factors can be potentially reduced in the elderly, it is important to carry out epidemiologic studies of HHcy. PROCEDURE: Previously we described the prevalence of hypertension control in an elder population; now, in an observational cross-sectional simple blind study, total homocysteine (tHcy) concentration was determined in 196 of 400 patients from the original cohort.
RESULTS: Mean Hcy concentration was 13.2 ,amol/L (95% confidence interval 12.4-14.0; range, 5.0 to 48.9); 15.0 ,imol/L for men and 12.3 pAmol/L for women. Mean serum folic acid levels were 4.9 + 3.1 ng/mL (range, 2.0 to 20.0 ng/mL), and vitamin B12 levels were 384.8 314.1 pg/mL (range, 48.0 to 1500.0 pg/mL). Taking into account the reference values established by the Third National Health and Nutrition Examination Survey III study, HHcy was detected in 69.8% of all the subjects evaluated. The study showed that 76.2% of the men and 66.4% of the women had high Hcy levels.
CONCLUSIONS: The very high prevalence of tHHcy in the elderly population, and the consequent risks associated with it suggest that although there are no trials that effectively prove the benefit of tHcy decrease, nutritional intervention is still justified.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12022240     DOI: 10.1016/s0895-7061(01)02165-3

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  6 in total

1.  Hyperhomocysteinemia leads to exacerbation of ischemic brain damage: Role of GluN2A NMDA receptors.

Authors:  Ankur Jindal; Sathyanarayanan Rajagopal; Lucas Winter; Joshua W Miller; Donald W Jacobsen; Jonathan Brigman; Andrea M Allan; Surojit Paul; Ranjana Poddar
Journal:  Neurobiol Dis       Date:  2019-03-15       Impact factor: 5.996

Review 2.  Hyperhomocysteinemia is an emerging comorbidity in ischemic stroke.

Authors:  Ranjana Poddar
Journal:  Exp Neurol       Date:  2020-12-03       Impact factor: 5.330

3.  Blood Flow Deficits and Cerebrovascular Changes in a Dietary Model of Hyperhomocysteinemia.

Authors:  David J Braun; Erin Abner; Vikas Bakshi; Danielle S Goulding; Elizabeth M Grau; Ai-Ling Lin; Christopher M Norris; Tiffany L Sudduth; Scott J Webster; Donna M Wilcock; Linda J Van Eldik
Journal:  ASN Neuro       Date:  2019 Jan-Dec       Impact factor: 4.146

4.  Microglial-associated responses to comorbid amyloid pathology and hyperhomocysteinemia in an aged knock-in mouse model of Alzheimer's disease.

Authors:  David J Braun; Edgardo Dimayuga; Josh M Morganti; Linda J Van Eldik
Journal:  J Neuroinflammation       Date:  2020-09-17       Impact factor: 8.322

5.  Hyperhomocysteinemia and its relations to conventional risk factors for cardiovascular diseases in adult Nigerians: the REMAH study.

Authors:  Babangida S Chori; Benjamin Danladi; Bassey A Inyang; Michael P Okoh; Maxwell M Nwegbu; Adewale L Alli; Augustine N Odili
Journal:  BMC Cardiovasc Disord       Date:  2021-02-18       Impact factor: 2.298

6.  Vitamin Status and the Development of Postoperative Cognitive Decline in Elderly Surgical Oncologic Patients.

Authors:  Linda B M Weerink; Barbara L van Leeuwen; Sofie A M Gernaat; Anthony R Absalom; Monique G Huisman; Hanneke van der Wal-Huisman; Gerbrand J Izaks; Geertruida H de Bock
Journal:  Ann Surg Oncol       Date:  2017-10-20       Impact factor: 5.344

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.